[144] Micron Technology, Inc. SEC Filing
Rhea-AI Filing Summary
Form 144 filed for Micron Technology (MU) reporting a proposed sale of 7,500 common shares through UBS Financial Services on Nasdaq with an aggregate market value of $981,201.75. The filer states the shares were acquired on 07/15/2025 upon an RSU/PSU release from the issuer and payment/settlement is shown as 07/15/2025. The filing discloses prior sales by related parties during June 2025 totaling 15,000 shares for gross proceeds of $1,737,812.88. The document includes the required attestation language about material nonpublic information and trading-plan representations.
Positive
- Full disclosure of acquisition details including acquisition date (07/15/2025) and nature (RSU/PSU release).
- Broker and market specified: UBS Financial Services and Nasdaq are identified for the planned sale.
- Prior related-party sales disclosed with dates and gross proceeds, enhancing transparency.
Negative
- None.
Insights
TL;DR This Form 144 reports a small planned sale of 7,500 shares from RSU/PSU proceeds; prior related-party June sales total 15,000 shares.
The filing shows the securities to be sold were acquired on 07/15/2025 via RSU/PSU release and are being placed with UBS Financial Services for sale on Nasdaq with an aggregate market value of $981,201.75. The number of shares outstanding is reported as 1,119,125,101, making the proposed sale de minimis relative to total float. Prior related-party dispositions during June 2025 are documented with dates and gross proceeds, providing transparency on recent insider-related selling activity.
TL;DR The filing appears procedurally complete and contains the standard insider attestation; amounts are small relative to outstanding shares.
The form includes the required representation that the seller is not aware of undisclosed material adverse information and lists prior sales by the Mehrotra Family Trust in June 2025. The inclusion of acquisition method (RSU/PSU release) and exact acquisition and planned sale dates aligns with Rule 144 disclosure expectations. There is no indication within this filing of a trading plan date or Rule 10b5-1 reliance entered in the remarks section.